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Abstract 
This paper aims to evaluate the mechanical behaviour of a bioresorbable polymeric coronary 
scaffold using finite element method, focusing on scaffold-artery interaction during degradation 
and vessel remodelling. A series of nonlinear stress-strain responses was constructed to match 
the experimental measurement of radial stiffness and strength for polymeric scaffolds over 2-
year in-vitro degradation times. Degradation process was modelled by incorporating the change 
of material property as a function of time. Vessel remodelling was realised by changing the size 
of artery-plaque system manually, according to the clinical data in literature. Over degradation 
times, stress on the scaffold tended to increase firstly and then decreased gradually, 
corresponding to the changing yield stress of the scaffold material; whereas the stress on the 
plaque and arterial layers showed a continuous decrease. In addition, stress reduction was also 
observed for scaffold, plaque and artery in the simulations with the consideration of vessel 
remodelling. For the first time, the work offered insights into mechanical interaction between a 
bioresorbable scaffold and blood vessel during two-year in-vitro degradation, which has 
significance in assisting with further development of bioresorbable implants for treating 
cardiovascular diseases. 
 2 
 
 
Keywords: Bioresorbable polymeric scaffold; Mechanical Interaction; Degradation; Finite 
element; Vessel remodelling 
 
1. Introduction 
Bioresorbable scaffolds, made of Poly (lactic-acid) (PLLA), are to provide temporary mechanical 
support for arterial lumen and then gradually absorbed in human body due to their degradation 
properties. The duration in which the polymeric scaffolds provide the mechanical support is 
called functional time, and the duration for the scaffold to degrade is referred as disappearance 
time (Lyu and Untereker, 2009). The use of bioresorbable scaffolds can reduce the risk of long-
term complications that may arise as a result of undesired biological response to a permanent 
implant, such as late stent thrombosis and chronic tissue inflammation. Moreover, there is no 
need to remove the stents for an additional surgical intervention. 
 
Experimental studies of degradation behaviour for a range of PLLA scaffolds have been widely 
carried out. Gong et al. (2007) investigated the in vitro degradation behaviour (i.e., weight loss, 
water uptake, molecular weight and morphology) of porous PLLA scaffolds over 39 weeks, and 
found that the scaffolds suffered degradation at a slow rate due to its highly porous structure. 
The in vitro degradation study by Liu et al. (2014) showed that PLLA porous scaffolds exhibited 
a reduction in mechanical properties (compressive modulus and strength), mass and molecular 
weight during a degradation time of 200 days. Rodrigues et al. (2016) carried out an in vitro 
degradation study of porous PLA scaffold immersed in phosphate-buffered-saline solution for 8 
weeks. The study revealed that there was no significant change for molecular weight, whereas 
compressive properties (i.e., compressive modulus and stress at yield) of the scaffolds maintained 
constant during the initial 6 weeks and increased significantly at week 8. Zamiri et al. (2010) 
conducted the in vitro degradation testing of PLLA and PLLA/PLGA braided scaffolds, and 
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their results showed that the mass loss was very limited for PLLA braided scaffolds up to 25 
weeks while 64% mass loss was found for PLLA/PLGA braided scaffolds. Grabow et al. (2007) 
conducted in vitro degradation study for a PLLA scaffold prototype in a deployed shape, and 
they found that collapse pressure increased firstly within 12 weeks and then deceased, while the 
molecular weight showed a gradual and steady reduction during the 24 weeks.  
 
Mechanical properties (i.e., ductility, toughness and strength) of biodegradable polymers change 
significantly during degradation, due to hydrolytic chain scission at molecule level. It is of 
importance to understand the mechanical behaviour of bioresorbable polymeric scaffolds during 
degradation period, especially for simulation and prediction of scaffold performance. Efforts 
have been made to describe the mechanical behaviour of biodegradable polymers during 
degradation. Soares et al. (2008) proposed a nonlinear constitutive model for degradable polymer, 
by introducing a scalar field variable that combined the degradation and mechanical (i.e., shear 
modulus) parameters. The proposed model was also applied in finite element analysis to 
investigate the mechanical response of PLLA scaffolds with different designs under constant 
external pressure (Soares et al., 2010). The results showed that PLLA scaffolds degraded faster at 
the bends of rings and junction points, with a loss of stiffness and a reduction of recoil. Vieira et 
al. (2011) tried to combine a hyperelastic model (Neo-Hookean or Mooney-Rivlin) with 
hydrolytic damage to predict the mechanical behaviour of biodegradable polymers during 
hydrolytic degradation process, and the numerical results were in good agreement with the 
tensile test data for PLA/PCL fibres. Luo et al. (2014) developed a thermodynamically consistent 
model for deformation-induced degradation, which was implemented in finite element 
framework to analyse the degradation of bioresorbable polymeric scaffolds. The simulated 
degradation rate and scaffold diameter change showed a good agreement with in vitro study. 
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On the other hand, several follow-up studies of clinical trials reported that vessel remodelling 
was observed following the implantation of bioresorbable scaffolds in humans and animals, by 
multiple invasive imaging methods such as multi-slice computed tomography (CT), angiography 
and Intravascular Ultrasound (IVUS). Ormiston et al. (2008) reported that the BVS 
(bioresorbable vascular scaffold) Absorb showed an angiographic in-scaffold loss of 0.44 mm 
and an overall 16.8% reduction of lumen area at 6-month follow-up after implantation in 30 
patients. Serruys et al. (2009) addressed the trial outcomes of Absorb after 2-year follow-up, in 
which the angiographic in-scaffold late loss was 0.48 mm and the lumen area increased from 5.19 
mm2 (at 6 months) to 5.47 mm2. Similarly, Serruys et al. (2010) evaluated the efficacy of Absorb 
for treatment of de novo coronary artery stenosis in 45 patients. At 6-month follow-up, the 
mean lumen area reduced by 3.1% (from 6.60 mm2 to 6.37 mm2) according to IVUS analysis. At 
2-year follow-up, the mean lumen area showed an increase (from 6.37 mm2 to 6.85 mm2) 
(Ormiston et al., 2012). Also, Serruys et al. (2011) successfully implanted 57 Absorb scaffolds in 
56 patients, and the 12-month follow-up results showed that there was a slight increase for the 
mean lumen area from 6.31 mm2 (Post-PCI) to 6.33 mm2. Recently, they reported 5-year follow-
up results after Absorb implantation, and they concluded that the mean lumen area tended to 
increase from 6 months to 1 year and 5 years (Serruys et al., 2016). Moreover, progressive lumen 
gain was also observed in porcine coronary arteries after Absorb implantation (Lane et al., 2014). 
The authors addressed that the lumen area retained stable from 1 to 6 months and then showed 
a progressive increase from 12 to 42 months. Therefore, vessel remodelling occurs in terms of 
lumen gain after scaffold implantation, and is yet to be considered in the study of scaffold-artery 
interaction. 
 
So far, most computational work has focused on the development and validation of material 
constitutive models that aim to predict the load-bearing, stress-strain behaviour of degradable 
polymer or implant (e.g., Soares et al., 2008; Vieira et al., 2011; Luo et al., 2014) or on the 
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simulations of polymer degradation with concurrent drug elution from degradable polymer 
coatings (e.g., Prabhu and Hossainy, 2006; Chen et al., 2011; Zhu and Braatz, 2014). However, 
computational studies characterizing both biodegradable implant mechanics and concomitant 
blood vessel stress is critically required. This can help predict the biological outcome due to 
progressively changing load-bearing property of a vascular implant considering scaffold 
degradation process. The objective of this study is to characterize scaffold-artery interaction 
during scaffold degradation, as well as vessel remodelling, using finite element method. 
Degradation behaviour was modelled by incorporating a series of nonlinear stress-strain 
responses constructed based on the experimental measurement of scaffold radial stiffness and 
strength over 2-years of in-vitro degradation. Vessel remodelling was realised by changing the 
size of plaque manually, according to the clinical measurements described in literature. Then the 
variation of stresses in scaffold and artery were presented and discussed. 
 
2. Calibration of stress-strain curves during in-vitro degradation 
2.1. Radial strength and stiffness of Absorb scaffold 
The radial strength and stiffness of Absorb scaffold was determined using the MSI RX550 Radial 
Force Tester. The scaffold itself is essentially made of PLLA, i.e., Poly-l-lactic acid, which is a 
semi-crystalline thermoplastic polymer and also widely used in medical implants in the forms of 
rods, plates and pins. The entire procedure can be divided into five steps: (I) sample preparation, 
(II) sample pre-conditioning, (III) scaffold deployment, (IV) scaffold measurement and (V) radial 
strength & stiffness testing. In step I, the catheter-balloon-scaffold system was removed from 
packaging, and then microscope was used to confirm that the crimped scaffold and balloon were 
properly aligned. In step II, the delivery system was soaked in water bath at 37°C for pre-
conditioning for at least 2 minutes. In step III, scaffold deployment in an expansion block was 
performed by balloon inflation. The balloon inflation and deflation procedures were completed 
in the water bath at 37°C. Afterwards, the expanded scaffold was removed from the water bath, 
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and the length was measured. Finally, in step V, the expanded scaffold was inserted into crimper 
head, and compressed to the nominal diameter. The pressure-diameter graph was obtained from 
this compression process, from which the radial strength and stiffness were determined. 
Specifically, as shown in Fig. 2, the black data points depict the increase in pressure measured as 
the diameter of the scaffold is decreased within the tester. The blue line (modulus) fits the linear 
portion of pressure-diameter curve, whose slope gives the radial stiffness. The radial strength is 
determined by the intersection of 0.1 mm offset line (red line) and the pressure-diameter curve. 
Using this method, the measured radial strength and radial stiffness values (normalised against 
the value at day zero) for bioresorbable polymeric scaffold at different in-vitro degradation time 
points are plotted in Fig. 2. It should be pointed out that all data were obtained for the Absorb 
scaffolds over a 2-year in-vitro degradation time (720 days), corresponding to virtually complete 
degradation. 
 
 
Fig. 1, Pressure-diameter graph obtained from the experimental testing (Absorb scaffold, Abbott 
Vascular). 
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Fig. 2, Radial strength and radial stiffness data for Absorb scaffold (Abbott Vascular). 
 
2.2 Calibration of stress-strain curves for PLLA during degradation 
The full procedure for calibrating PLLA stress-strain curves is shown in Fig. 3. The stress-strain 
behaviour was used as model input. Then a simulation was performed to evaluate radial strength 
and stiffness of scaffold, according to the experimental testing method described above. 
Specifically, the scaffold was crimped in the first crimping step, in which the displacement 
loading was applied to 12 rigid plates to compress the original scaffold onto the balloon (as 
further explained in the following; see Fig. 4b). Afterwards, the crimped scaffold was expanded 
by balloon inflation, followed by balloon deflation to allow scaffold recoil to occur. The second 
crimping was subsequently modelled to produce the radial pressure-diameter curve, which was 
used to determine the radial strength and radial stiffness of the deployed scaffold. This process 
was performed iteratively, i.e., tuning the stress-strain curves until the simulated radial strength 
and stiffness match the measured ones. This method is essentially an “inverse” curve-fitting 
process, for which an iterative adjustment process was used to adjust the stress-strain curve until 
the simulated radial stiffness and strength matched the test data. 
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Fig. 3, Flow chart for calibration of PLLA stress-strain curves. 
 
Abaqus 6.14 CAE was used to build the 3D finite element models for Absorb scaffold (Fig. 4a). 
The scaffold modelled was 12.66 mm in length and has 13 ring units connected by axial struts 
(Fig. 4a). Each ring unit has 3 peaks and 3 valleys (Fig. 4a). Dimensions of the Absorb scaffold 
were measured using OGP flash 200 Microscope. The thickness and width of struts are 150 μm, 
while the width at U-bend is 200 μm (Fig. 4a). To create the model (Fig. 4a), three steps are 
required: (i) creating the flat pattern of scaffold, (ii) partitioning and meshing the flat model and 
(iii) wrapping the meshed flat model to produce tubular model. The flat model is a 2D version of 
the scaffold (cut the scaffold open in longitudinal direction), which was then revolved into 3D 
scaffold using the “wrap-up” tool in ABAQSU CAE. Since this wrapping procedure is only a 
geometrical operation rather than a mechanical procedure, there is no residual stress generated in 
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the scaffold. Hexahedral 8-node elements with reduced integration (C3D8R) were used to mesh 
the scaffold (Fig. 4a). There are 5 layers of elements through the thickness direction and 6 layers 
of elements through the width direction (Fig. 4a; based on our mesh sensitivity study). The 
mechanical property for virgin PLLA was found in Pauck and Reddy (2015) who obtained stress-
strain curve through performing uniaxial tensile tests. The stress-strain response was already 
reported in our recently published papers (Schiavone et al., 2016; 2017) and thus omitted here. 
For the PLLA material, the density is 1.4×10-6, Young’s Modulus is 2200 MPa and Poisson Ratio 
is 0.3. In simulation, plastic behaviour was described by providing the yield stress as a function 
of plastic strain extracted from the stress-strain curve (Schiavone et al., 2016; 2017). Yielding 
refers to the transition from linear elastic deformation to nonlinear plastic deformation, and the 
stress level corresponding to this transition point is called yield stress.  
 
NX 8.5 (Siemens PLM Software, UK) was used to create the tri-folded balloon model (Fig. 4a). 
Specifically, a series of projected curves were created on four uniformly distributed datum planes, 
with a largest diameter of 0.4 mm in fully folded configuration. These cross-sectional sketches 
were further extruded to produce the 3D shell by using the sweep tool. Then the 3D shell was 
imported into Abaqus CAE to produce the final geometry of tri-folded balloon model (Fig. 4a). 
The length of tri-folded balloon is 16 mm for the middle part, and the fully inflated diameter is 
about 3.2 mm. Four-node quadrilateral membrane element was chosen to mesh the balloon (Fig. 
4a). The balloon was defined as an isotropic and linear-elastic material, with Young’s Modulus of 
900 MPa and Poisson Ratio of 0.3 (Gervaso et al., 2008). 
 
For scaffold crimping, 12 rigid plates (Fig. 4b) were built to squash the scaffold onto the balloon 
controlled by enforced displacement loading (Schiavone et al., 2016). Both ends of balloon were 
fully constrained during the simulation and hard contact between scaffold outer surface and rigid 
plates was specified with a friction coefficient of 0.8. An additional spring back step was also 
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included by releasing the 12 rigid plates after scaffold crimping, which allowed for a recovery of 
elastic deformation of the crimped scaffold. Images of the simulated scaffold crimping are 
shown in Fig. 4c.  
 
The radial strength and radial stiffness of the virgin Absorb scaffold were obtained from the 
simulations using the original PLLA stress-strain curve. The PLLA stress-strain curves at 
different degradation time points were artificially constructed, and then used as the input to 
predict radial strength and stiffness results. The goal of this process is to match the simulated 
scaffold stiffness and strength with the experimental measurements in Fig. 2 by tuning the 
constructed stress-strain curves. The process is an iteration process based on trial and error as 
shown in Fig. 3. Here, the radial strength and stiffness, normalised to the virgin state (i.e., zero 
time point), were used for fitting the stress-strain curves of PLLA at different degradation time 
points (Fig. 2). 
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Fig. 4, FE mesh for balloon-scaffold assembly (a), assembly of 12 rigid plates (b), and simulation 
of Absorb scaffold crimping by applying 1 mm displacement loading on rigid plates (c). 
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3. Crimping and expansion of scaffold in diseased artery 
3.1 Finite element model 
FE models for the Absorb scaffold and a tri-folded balloon are the same as described above. For 
the artery, a three-layered model was created, and had an inner diameter of 3 mm and a length of 
40 mm (Fig. 5). The overall thickness of arterial wall is 1 mm, including 0.38 mm adventitia layer, 
0.33 mm media layer and 0.29 mm intima layer (Fig. 5). Here, the artery refers to left anterior 
descending coronary artery, with the thicknesses of individual layers given in Holzapfel et al. 
(2005). Plaque was modelled as a symmetric layer inside the artery, with a length of 10 mm and a 
stenosis of 50% (inner diameter is 1.5 mm). Hexahedral brick elements with reduced integration 
(C3D8R) behaviour were used to mesh the artery and plaque (Fig. 5). In the radial direction, the 
artery was meshed with 4 rows of elements for each tissue layer and the plaque was meshed with 
8 rows of elements (Fig. 5). In the longitudinal direction, the element size for artery was 
increasing from the middle to both end sides by using bias control method (Fig. 5).  
 
3.2 Constitutive models for plaque-artery 
Constitutive models for Absorb scaffold and tri-folded balloon are the same as described above. 
For three-layered artery, the Holzapfel-Gasser-Ogden (HGO) model was used to describe the 
anisotropic behaviour of the arterial layers (with collagen fibres). In this study, it is assumed that 
there are two families of collagen fibres embedded in a soft incompressible matrix within each 
arterial layer. The model was calibrated by taking the average stress-stretch curves that were 
measured and obtained from 13 patients (Holzapfel et al., 2005). The calibrated parameter values 
for the HGO model were given in our previous paper (Schiavone et al., 2017) and the simulated 
longitudinal and circumferential stress-stretch responses of three layers were in excellent 
agreement with the experimental results (Schiavone et al., 2017). For the hypocellular plaque, the 
first order hyper elastic Ogden strain energy potential (Ogden, 1972) was used here, and material 
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parameters were calibrated against test data (Loree et al., 1994) and given in Zahedmanesh and 
Lally (2009). Our own simulations verified that the stress-strain curve modelled with these 
parameters was in good agreement with experimental data reported in Loree et al. (1994).  
 
3.3 Simulation of crimping and deployment 
Similarly, in scaffold crimping process, 12 rigid plates were first assembled around the scaffold 
(Fig. 4b), and the distance between central axis of scaffold and rigid plate is 1.6 mm. A linearly 
increasing displacement loading was applied on the surface of 12 rigid plates along radial 
direction, to squeeze the original expanded scaffold. The maximum displacement is 1 mm. As a 
result, the biodegradable polymeric scaffold was radially compressed down to an outer diameter 
of 1.2 mm. The scaffold was crimped onto the balloon in the end, meanwhile both ends of 
balloon were fully constrained because they were fixed on the catheter in the actual situation (Fig. 
4c). After crimping, an additional step was added to remove the 12 rigid plates, allowing the 
crimped scaffold to spring back freely (Fig. 4c). Fig. 5 shows the scaffold-balloon-artery 
assembly after crimping process. 
 
 
Fig. 5, Crimped scaffold-balloon-artery assembly obtained from crimping process. 
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Scaffold expansion in diseased artery procedure consists of inflation step and deflation step. The 
inflation step was performed by applying pressure on the inner surface of balloon. The uniform 
pressure was linearly increasing from 0 to 1.4 MPa. Both ends of the artery were fully 
constrained to describe the constraint in the human body environment. The applied constraints 
are also at a significant distance from the edges of the scaffold and have minimal effects on the 
stress-strain distributions in the region of interest (i.e., diseased or stented region). Interactions 
between the artery, scaffold and balloon were modelled as surface to surface hard contacts with a 
frictional coefficient of 0.25 (Ju et al., 2008). Subsequently, the deflation step was modelled by 
releasing the pressure on the inner surface of balloon, which allowed the expanded scaffold to 
recoil freely. Interactions between scaffold, the balloon and the plaque were maintained in this 
step. 
 
4. Modelling of scaffold-artery interaction during degradation  
Fig. 6 shows the full simulation procedures to investigate the scaffold-artery interaction during 
degradation process. Firstly, pre-processing was performed to implant the scaffold in stenotic 
artery. In the pre-processing procedure, crimping, spring back (crimp recoil), inflation and 
deflation steps were simulated, by implementing the original PLLA stress-strain behaviour. The 
geometry and mesh for the scaffold and artery/plaque were described above. Subsequently, 
scaffold degradation process was modelled by changing the PLLA stress-strain behaviour as a 
function of degradation time. The change in PLLA stress-strain behaviour was controlled by a 
field variable, i.e., the mechanical property of polymer PLLA depends on the field variable values. 
Field variable was used to link stress-strain behaviour with degradation time. In this paper, 
different values (from 1 to 11) of field variable were used to represent the stress-strain behaviour 
at 11 degradation time points (i.e., day 0, 30, 92, 189, 272, 365, 442, 545, 601, 659 and 729) 
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considered in this paper. The simulations over degradation were carried out in 11 consecutive 
steps, and for each step, a unique value of field variable is assigned, based on which the 
corresponding material behaviour is picked up automatically by ABAQUS for the simulations. At 
the same time, cyclic blood pressure was applied to capture the pulsatile vasomotion of artery. In 
order to simulate the systolic-diastolic fluctuations, a pressure in realistic waveform fluctuating 
between 80 mmHg and 120 mmHg (Fig. 7), was applied on the inner surface scaffold and artery, 
and 10 cycles were modelled in this study. The residual stresses induced to the scaffold by the 
deployment were not directly considered in our simulations. This is a limitation of the current 
study as the ABAQUS solver does not allow us to consider both residual stress and material 
property change simultaneously. But we believe that residual stresses will also change gradually 
and eventually diminish during material degradation. Future work is required to characterize how 
residual stresses will be reduced over degradation times. However, the in vitro degradation data 
(Fig. 2), and hence the calibrated stress-strain curves over degradation times, already accounted 
for material history effects such as any plastic strains, evolution of crystallinity and stress 
relaxation incurred during scaffold deployment as well as any effects due to residual stresses 
presented in the scaffolds at the beginning and changes thereof during degradation. In other 
words, any local or regional degradation interactions with scaffold history (crimping and 
expansion) and residual stresses are factored in the stress-strain curves calibrated and used in the 
finite element simulations (e.g. Fig. 10). 
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Fig. 6, Flow chart for the simulation procedure. 
 
 
Fig. 7, Blood pressure with realistic waveforms. 
 17 
 
 
5. Modelling of scaffold-artery interaction during vessel remodelling 
Generally, lumen area is measured by intravascular ultrasound method, which showed an 
increase over 2-year period of degradation for Absorb. This is referred as vessel remodelling. In 
this study, vessel remodelling was realised by changing the lumen diameter of artery-plaque 
system manually, based on the clinical data in literature. According to Serruys et al. (2013), the 
mean vessel area, mean lumen area and mean plaque area increased from 14.13 mm2, 6.43 mm2 
and 7.7 mm2 at post-procedure to 15.31 mm2, 6.89 mm2 and 8.42 mm2 at 2 years for patients 
implanted with Absorb scaffolds. By translating to diameter change, it was found that the vessel 
outer diameter, the lumen diameter and plaque thickness were increased by 4.1%, 3.5% and 5.3% 
over two years. This percentage of increase has been used in this study to simulate the effect 
vessel remodelling on scaffold-artery interaction. Specifically, the plaque-artery configuration 
obtained directly from the simulation of scaffold deployment was taken as a reference state (day 
0), which gave a vessel diameter of 5.38 mm (“D” in Fig. 8), a lumen diameter of 2.26 mm (“d” 
in Fig. 8) and a plaque thickness of 0.64 mm (“t” in Fig. 8). Over two years, the vessel diameter, 
lumen diameter and plaque thickness increased to 5.60 mm, 2.34 mm and 0.67 mm (see Fig. 8 
and Table 1). For blood vessel, it was the thickening of media layer that contributed to the vessel 
area increase and consequently, only the thickness change of media layers (a 9.0% increase) was 
considered while the other two layers were kept unchanged. Then the manually constructed 
artery-plaque model, with the implanted scaffold inside, was used to simulate the scaffold-artery 
interaction after vessel remodelling over 2 years. Again, cyclic systolic-diastolic blood pressure 
(Fig. 7) was applied to the scaffold-artery system. It should be noted that the degraded stress-
strain curve calibrated for 792 days was used for simulation of scaffold-artery interaction. For the 
reference state (i.e., 0 day or immediately after deployment), the original stress-strain curve was 
used for simulation of scaffold-artery interaction. 
 
 18 
 
 
Fig. 8, Schematic of vessel and lumen diameters for artery-plaque system. 
 
Table 1, Values of vessel diameter, lumen diameter and plaque thickness used in simulation. 
 No remodelling  (0 day) 
With remodelling  
(792 days) 
Vessel diameter D (mm) 5.38 5.6 
Lumen diameter d (mm) 2.26 2.34 
Plaque thickness t (mm) 0.64 0.67 
 
As part of changing the geometric boundaries of each artery layer (akin to “surface remodelling”), 
cross sectional thickness was increased for both plaque and media in our modelling approach to 
capture passive aspects of vessel remodelling. These geometric changes affect the remodelled 
plaque-artery stiffness and its chronic interaction with the scaffold, but do not address any 
changes of material properties occurring in the artery layer over time. The increase of media 
thickness applied in our models approximates the neointimal thickening behaviour that is known 
to occur in the intima-media layers after stenting and closely associated with the extent of 
vascular injury (Rogers and Edelman, 1995; Sullivan et al., 2002; Bennett, 2003). This was 
prescribed in a way that is compatible with the percentage change prescribed by Serruys et al. 
(2013). The exact delineation between the intima and media layers is difficult to discern in 
histologic practice so the increase prescribed in our work was applied to the media layer only. In 
addition, smooth muscle cells are known to infiltrate from the media into the intima during in-
stent restenosis. This supports that the media effectively “grows” as we modelled it. However, 
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we did not model any cellular changes in this work which is hugely complex and beyond the 
scope of current work. 
 
6. Results 
6.1 PLLA stress-strain behaviour over degradation 
Fig. 9 shows the radial pressure-diameter curve obtained from simulation of re-crimping process 
for the Absorb scaffold, using the original PLLA stress-strain behaviour (i.e., no degradation). 
The dashed line followed the linear portion of the pressure-diameter curve, and the dashed-
dotted line is the 0.1 mm offset line. As a result, the calculated radial stiffness and strength are 
4625 mmHg/mm (61.66 MPa) and 1900 mmHg (25.33 MPa), respectively, for the Absorb 
scaffold at day 0. Following the same method, the radial stiffness and strength values for the 
scaffold can be obtained using artificially constructed PLLA stress-strain curves at different 
degradation time points. The artificially constructed stress-strain curves were then tuned until the 
obtained radial stiffness and strength values, normalised against those at day 0, matched the 
experimental measurements in Fig. 2. Here, it was assumed that the rate of plastic hardening was 
not affected by degradation.  
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Fig. 9, Radial pressure-diameter curve obtained from re-crimping process for Absorb scaffold. 
 
The back calculated PLLA stress-strain curves are given in Fig. 10 at different degradation time 
points. “Back calculation” refers to obtaining the stress-strain curve of the material which gives 
the same radial stiffness and strength of the scaffold as experimental measurements. This 
involves an iterative adjustment process until the simulated radial stiffness and strength match 
the experimental data (See Section 2.2 and Fig. 3). The normalised radial stiffness and strength 
for the scaffold, obtained using calibrated PLLA stress-strain curves at different degradation time 
points, are shown in Fig.11, which are in agreement with the experimental data. In Fig. 10, the 
red line with square symbols refers to the original stress-strain behaviour for PLLA. Overall, 
there is no significant change in the Young’s modulus, because of small difference is observed 
for the radial stiffness of scaffold that is mainly controlled by Young’s modulus of polymer. 
While the yield stress has a significant increase in the early time points (up to 365 days) due to 
the recrystallization of polymer, and then decreases quickly. 
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Fig. 10, Constructed PLLA stress-strain curves for Absorb scaffold at different degradation time 
points. 
 
 
Fig. 11, Radial strength and stiffness data obtained from simulation for Absorb scaffold 
compared to experimental data at different degradation time points. 
 
6.2 Stress variation on the scaffold over degradation 
Degradation caused significant variations for the von Mises stress on the scaffold (Fig. 12). 
Clearly, high stresses (red zones) are mainly located at the corners of U-bend struts, especially in 
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the middle part of the scaffold structure. Due to the weakening of material property, stress 
concentration spreads towards both ends of scaffold, indicating a spatial change of stress 
distribution as a result of temporal degradation. The maximum von Mises stress value on the 
scaffold is 101.93 MPa (Fig. 12a), 120.39 MPa (Fig. 12b), 116.68 MPa (Fig. 12c), 66.70 MPa (Fig. 
12d) and 43.67 MPa (Fig. 12e) at degradation time of 0 day, 189 days, 365 days, 659 days and 729 
days, respectively.  
 
Fig. 13 plots the variation of maximum von Mises stress on the scaffold over the degradation 
time of 729 days. It could be concluded that the maximum von Mises stress increases up to 365 
days and then decreases quickly, corresponding to the change in stress-strain behaviour of 
scaffold material. Between 30 days and 365 days, no significant difference is observed for the 
maximum stress value on the scaffold, because the stress-strain behaviour of scaffold material is 
very similar over the period. Beyond 365 days, the stress starts to reduce, with dramatic 
reduction after 545 days. Specifically, the maximum von Mises stress is reduced from 115.16 
MPa at 545 days to 43.67 MPa at 729 days (Fig. 13). Significant stress loss indicates that the 
biodegradable scaffold might lose mechanical integrity after 545 days when it is likely being 
absorbed by the human body. In this section, we did not consider the effect of vessel 
remodelling, so plaque and artery experienced no change. Vessel remodelling (i.e., geometrical 
change) is considered in Section 6.4. 
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Fig. 12, Von Mises stress distribution on the scaffold at a degradation time of 0 day (a), 189 days 
(b), 365 days (c), 659 days (d) and 729 days (e). 
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Fig. 13, Maximum von Mises stress on the scaffold over degradation. 
 
6.3 Stress variation in the artery-plaque system over degradation 
From the contour plot of the maximum principal stress on the plaque (Fig. 14), it is seen that the 
peak value continuously decreases with degradation after six months of implantation, with values 
of 0.711 MPa (Fig. 14b), 0.702 MPa (Fig. 14c), 0.662 MPa (Fig. 14d) and 0.500 MPa (Fig. 14e) at 
degradation times of 189 days, 365 days, 659 days and 729 days, respectively. In addition, the 
area exhibiting higher stresses (red zone) also decreases progressively during scaffold degradation. 
As a result, the regions of high-level stress shrink significantly at both ends of plaque where a 
strong contact exists between the scaffold and plaque due to the dogboning effect (Fig. 14). The 
lower stress, combined with a smaller region of stress concentration, is an indication of reduced 
mechanical load on the vessel wall. Stress reduction is a gradual process and according to our 
simulations, significant arterial stress reduction occurs after one and half years of degradation. 
This behaviour is expected since the scaffold is designed to disappear over two years (i.e., when 
no longer needed to support the artery) and arterial stress reduction in this later time period 
occurs after the scaffold struts have been integrated with overgrown tissue (Serruys et al., 2013). 
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This means that degrading scaffold struts are unlikely to directly interact with long-term blood 
flow. 
 
 
 
Fig. 14, Contour plot of the maximum principal stress on plaque at a degradation time of 0 day 
(a), 189 days (b), 365 days (c), 659 days (d) and 729 days (e). 
 
The contour plots of the maximum principal stress in the intima, media and adventitia layers are 
shown in Fig. 15 to Fig. 17, respectively. For the intima layer, the peak maximum principal stress 
increases significantly for the segment covered with plaque (i.e., from 0.266 MPa at day 0 to 
0.281 MPa at day 189; Fig. 15a and b), followed by a gradual decrease over the rest period of 
degradation (i.e., 0.276 MPa at 365 days, 0.254 MPa at 659 days and 0.192 MPa at 729 days; Fig. 
15c, d and e). The stress in the intima layer is concentrated over the plaque-covered segment, 
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especially at both end sides due to scaffold dogboning (Fig. 15). For the media layer, a gradual 
decrease was found for the peak maximum principal stress over degradation time, with a value of 
0.022 MPa at day zero (Fig. 16a) and a reduction to 0.021 MPa (4.5% reduction; Fig. 16b), 0.019 
MPa (13.6% reduction; Fig. 16c), 0.017 MPa (22.7% reduction; Fig. 16d) and 0.013 MPa (40.9% 
reduction; Fig. 16e) at day 189, 365, 659 and 729, respectively. The area of high level stress is also 
considerably reduced (Fig. 16). For the adventitia layer, both the peak maximum principal stress 
and the stress-concentration area are similar at a degradation time of up to 659 days (Fig. 17). 
Specifically, the peak maximum principal stress has a magnitude of 0.01-0.009 MPa, and the 
stress concentration is again found at both ends of plaque-covered segment (Fig. 17). After 729 
days, a clear reduction of stress concentration area is observed while the peak maximum 
principal stress remains almost unchanged (0.008 MPa; Fig. 17e). 
 
 
Fig. 15, Contour plot of the maximum principal stress on the intima layer at a degradation time 
of 0 day (a), 189 days (b), 365 days (c), 659 days (d) and 729 days (e). 
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Fig. 16, Contour plot of the maximum principal stress on the media layer at a degradation time 
of 0 day (a), 189 days (b), 365 days (c), 659 days (d) and 729 days (e). 
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Fig. 17, Contour plot of the maximum principal stress on the adventitia layer at degradation time 
of 0 day (a), 189 days (b), 365 days (c), 659 days (d) and 729 days (e). 
 
To provide further insights into stress variation in the artery over degradation, Fig. 18 shows the 
spatial distribution of the average maximum principal stress (volume average along the 
circumferential direction) for the three individual arterial layers along the longitudinal direction at 
degradation time of 0 day, 365 days and 729 days. Significant stress reduction is observed over 
the plaque-covered part of three individual arterial layers, especially from 365 days to 729 days of 
degradation time (Fig. 18). It could be concluded that the maximum principal stress on the 
plaque-artery system has a continuous reduction over degradation process after one-year 
implantation, due to the weakening of stress-strain behaviour of scaffold material. Stress 
reduction may in fact avoid inducing undesired chronic biological responses like cellular injury or 
inflammation, promoting vessel remodelling. 
 29 
 
 
Fig. 18, The spatial distribution of the average maximum principal stress in three arterial layers at 
degradation time of 0 day, 365 days and 729 days. 
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6.4 Effects of vessel remodelling 
Contour plot of von Mises stress on the scaffold shows that stress distribution and reduction at 
two-year degradation time are similar to those presented above, indicating negligible effect of 
vessel remodelling. Basically, stresses are concentrated at the U-bend struts and significant stress 
reduction is observed on the scaffold over 2-year degradation time due to the loss of modulus 
and strength. It should be noted that residual stresses generated from scaffold crimping are not 
considered due to model limitations. Here, the stresses and deformation are mainly caused by the 
balloon inflation and the applied blood pressure. 
 
Fig. 19, The contour plot of von Mises stress on the plaque at 0 day (a) and 729 days without 
vessel remodelling (b) and with vessel remodelling (c) after 10 cycles of pulsatile blood pressure. 
 
Fig. 19 shows the contour plot of von Mises stress on the plaque at 0 day and 729 days subjected 
to 10 cycles of pulsatile blood pressure. Stress concentrations are located at bridge strut-covered 
part of the plaque, and stress on the inner surface is higher than that on the outer surface. Also, 
stress reduction is observed on the plaque, which is around 0.040 MPa (14.5%; Fig.19c) and 
0.026 MPa (9.5%; Fig.19b) for simulations with and without considering the vessel remodelling. 
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This indicates that vessel remodelling is accompanied by further reduction of stresses in the 
scaffold-plaque system. 
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Fig. 20, The contour plot of von Mises stress on the intima, media and adventitia layers at 0 day 
(a) and 729 days without vessel remodelling (b) and with vessel remodelling (c) after 10 cycles of 
pulsatile blood pressure. 
 
Contour plots of von Mises stress are also given for the three individual arterial layers at 0 day 
and 729 days (with and without vessel remodelling) after 10 cycles of pulsatile blood pressure 
(Fig. 20). Stresses are mainly concentrated at both ends of arterial layers, corresponding to the 
regions of stress concentration at the scaffold edges. For the intima layer, the maximum stress 
values are reduced by 0.017 MPa (12.2%) and 0.005 MPa (3.6%) for simulations with and 
without vessel remodelling (top subfigure in Fig. 20). For the media layer, relative stress loss is 
more significant, around 37.5% (0.006 MPa) and 6.3% (0.001 MPa) for simulations with and 
without vessel remodelling (middle subfigure in Fig. 20). For adventitia layers, it seems that no 
difference is observed for the maximum von Mises stress (bottom subfigure in Fig. 20). Vessel 
remodelling is based on follow up studies of clinical trials (Serruys, 2009; Serruys, 2010; Serruys, 
2011 and Serruys, 2016). In terms of lumen gain, the observed vessel changes represent a 
positive remodelling process. However, the vessel cross-sectional area increased during 
remodelling. Due to the complex interplay of the biological processes which drives these 
remodelling changes, we mainly focused on effect of vessel remodelling (i.e., geometrical change) 
on the interaction between scaffold and blood vessel.  
 
7. Discussions 
Due to their biodegradation characteristics, bioresorbable scaffolds have advantages in 
overcoming long-term clinical complications (e.g. restenosis, thrombosis and inflammation) 
associated with permanent metallic stents. Degradation is also the key factor that influences the 
mechanical performance of bioresorbable scaffolds after deployment. However, existing studies 
have been focused on predicting the degradation behaviour of polymeric scaffolds, including the 
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influence of deformation. For instance, Soares et al. (2010) applied a thermodynamically 
consistent constitutive model to predict degradation behaviour of PLLA scaffolds. Degradation 
of three different scaffold designs was modelled, and results showed that high risk of 
degradation was mainly observed at the bends of scaffold rings and junction points due to high 
levels of deformation. Luo et al. (2014) developed a numerical model to study the degradation 
behaviour of bioabsorbable PLLA scaffold, by combining the degree of degradation with pre-
stretched deformation. Results showed that degradation happened throughout the whole 
scaffold over 30 days, but the degradation rate was not uniform. The maximum degradation was 
observed at the inner surface of U-bend strut where the stress concentration/maximum strain 
occurred during scaffold expansion, which was in good agreement with experimental result. 
Basically, this indicates that there is an interaction between deformation and degradation, and 
high levels of deformation or stress facilitate the transport of water into the material and 
accelerate the degradation process (Luo et al., 2104). However, there is little research on 
modelling the deformation of biodegradable polymeric scaffold by considering the effect of 
scaffold material degradation because of the lack of stress-strain data during degradation. This 
paper is the first attempt to obtain the mechanical response of PLLA during two-year 
degradation times. From the constructed stress-strain behaviour of PLLA, we can see that both 
the yield stress and modulus had an increase up to a period of 15 months, corresponding to the 
increase of radial strength and radial stiffness of PLLA scaffold determined in experiments. It 
indicates that the radial strength and stiffness of scaffold are mainly controlled by the yield stress 
and Young’s modulus of scaffold material. From the material point of view, the initial increase of 
yield stress and Young’s modulus might be caused by the recrystallization of biodegradable 
polymer PLLA due to the water absorption and temperature increase (from room temperature 
20°C to human body temperature 37°C). It was reported that crystallization can significantly 
improve the mechanical strength and stiffness of PLLA in literature (Perego, 1996). For instance, 
the amorphous PLLA presents a tensile strength of 55-59 MPa whereas the crystalline PLLA has 
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a tensile strength of 60-70 MPa. In addition, it was also reported that PLLA could be potential 
material candidate for applications at a temperature of 40°C or higher, because the crystallization 
can significantly improve the mechanical properties. In addition, the radial strength of scaffold 
reduced quickly after 365 days, but the significant reduction in radial stiffness occurred after 659 
days. This suggested that the yield stress of PLLA was more sensitive to hydrolysis degradation 
compared to Young’s modulus, i.e., degradation leads to faster change of yield stress compared 
to Young’s modulus. This has not been reported in literature yet. However, this conclusion is 
based purely on our finite element simulation results, and requires supportive experimental 
evidence. Also, in this paper, we have not modelled the physical degradation of scaffold itself. 
We focused on the mechanical property change caused by degradation. Such behaviour is 
reflected by the stress plot of the scaffolds over two-year degradation times (see Fig. 12). 
 
In percutaneous coronary intervention (PCI), scaffold implantation induces high stresses on the 
arterial wall, which may generate negative effects such as injury to arterial tissue. Therefore, it is 
important to evaluate the stress state generated in the plaque-artery system during scaffold 
deployment process. It is a challenge to measure the stresses generated in the scaffold-artery 
system using experimental methods, due to the complicated process and complex geometrical 
factors. So far, finite element method was dominantly used to reveal the stress state in the artery 
following the deployment of scaffolds. An ideal process of scaffold deployment requires an 
expansion which is sufficient to clear vessel obstructions and also induces minimal damage to the 
vessel walls (Farooq et al., 2011), as in-stent restenosis can be triggered by unsuccessful 
treatments including vessel over-stretch and injury, incomplete expansion of the scaffold and 
fracture of the scaffold struts. Both Imani et al. (2014) and Lally et al. (2005) confirmed a direct 
correlation between arterial wall stresses and restenosis rate. Similarly, study on scaffold-artery 
interaction during degradation is necessary to evaluate the safety and efficacy of polymeric 
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scaffolds, but little work is available in the literature. Again, this paper is the first attempt to 
evaluate the mechanical interaction between a bioresorbable scaffold and a diseased artery over 
the process of scaffold degradation. According to our results, at the end of two-year degradation, 
a trend of stress reduction was generally observed for both scaffold and plaque-artery system in 
the simulation of scaffold-artery interaction by changing the stress-strain behaviour of scaffold 
material and applying pulsatile blood pressure. Over degradation times, the stress variation on 
the scaffold showed an increase firstly before a gradual decrease, which was consistent with the 
change of yield stress for the scaffold material. For scaffold, the maximum von Mises stress 
reduced to 43 MPa at 729 days (~2 years), indicating the loss of mechanical integrity and support 
due to scaffold degradation. As reported in a clinical follow-up study by Serruys et al. (2009), the 
bioresorbable everolimus-eluting scaffold was fully absorbed at 2 years as revealed by means of 
multi-imaging approaches including echogenicity, virtual history and optical CT. However, the 
stress on the plaque and arterial layers showed a general decrease over scaffold degradation. For 
the plaque-artery system, relatively high principal stress (0.706 MPa at 0 day) was generated when 
the scaffold was implanted through full expansion. Then, the principal stress on the plaque-
artery system became lower and lower (reduced to 0.5 MPa at 729 days) over degradation time 
when subjected to pulsatile blood pressure, which can be regarded as occurring in concert with 
the natural healing process of the artery. 
 
Long-term lumen gain after implantation of Absorb scaffolds has been reported in a series of 
clinical trial studies (Serruys, 2009; Serruys, 2010; Serruys, 2011 and Serruys, 2016). The 
intravascular ultrasound examination showed that a positive increase occurred to the mean 
luminal area (as well as minimal luminal area) between 6 months and 2 years. These 
measurements provide evidence of vessel remodelling, or more specifically positive remodeling. 
Accompanying this lumen gain, an increase in plaque size and vessel area was also noticed. 
Vessel remodelling has been simulated in this study in order to reveal its effect on the stress-
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strain interaction between scaffolds and artery after two years of implantation. During vessel 
remodelling, both scaffold and plaque exhibited stress reduction. Stress reduction was also 
observed for the intima and media layers of artery, but almost no difference was found for the 
adventitia layer. This may offer an understanding of the healing process of injured vessel walls 
after scaffold deployment, from a mechanical point of view. Generally, vessel remodelling refers 
to a change of both geometry and mechanical property, caused by histological structure change 
and external loads. However, in this study, vessel remodelling was modelled by changing vessel 
geometry (increase the lumen diameter, plaque size and media layer thickness) manually, without 
considering the evolution of tissue property and its intrinsic residual stress. Also to our best 
knowledge, vessel remodelling is a very complex process and still not fully understood yet (Goel 
et al., 2012). The major biomechanical stimuli include contributions from both mechanical 
deformation and vessel haemodynamics such as wall stress, wall shear stress, blood pressure, 
blood flow and hypertension (Wentzel et al., 2001; Goel et al., 2012). For instance, low wall shear 
stress is associated with constrictive vascular remodelling while high wall stress is attributed to an 
increase in wall area (Wentzel et al., 2001). In addition, biological factors such as transforming 
growth factor beta (TGF-β) and matrix metalloproteinases (MMP) also play key roles in vessel 
remodelling after stenting (Goel et al., 2012). For instance, TGF-β1 is a potent contributor to 
constrictive remodelling while MMP-9 overexpression was found to reduce lumen loss by 
promoting adaptive remodelling (Goel et al., 2012). But, it should be noted that it is very difficult 
to tell exactly how these factors govern vessel remodelling, due to the complexity of the topic as 
well as the sophisticated interactions between all the biomechanical and biological factors. 
Further work is required to elucidate such effects in detail, however, the present work offers a 
signal of how the artery-plaque system’s mechanical behaviour generally changes over time. 
 
Systolic-diastolic stress will introduce cyclic stresses within the scaffold. However, estimated 
fatigue stresses are considerably lower than the stresses imposed in the scaffold during acute 
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expansion of the scaffold (stress amplitude less than 5% of acute maximum stress during 
expansion; Qiu, 2017). Rigorous calculation of fatigue safety factors has been attempted for 
scaffolds in prior works (Li et al., 2010; Azaouzi et al., 2012), however, traditional Goodman 
analyses (mean stress effect) provide only a rough assessment of fatigue resistance suitable for 
simple comparisons between scaffold designs, given that this technique is best suited for 
predicting failure in ductile metals and not polymers. Due to the complexity of accurately 
predicting the fatigue behaviour of polymeric scaffolds, it is considered beyond the scope of this 
work and the capability of current modelling techniques. Experimental fatigue-resistance 
characterization (S-N curves) and long-term device verifications performed by manufacturers 
such as Abbott are not available to us due to confidentiality reasons, however, extensive clinical 
trial data for the Absorb scaffold have confirmed that the product is efficacious and promotes 
safe tissue coverage without any mentioned indications of scaffold fatigue fractures. 
 
Finally, degradation behaviour of polymeric scaffolds was attempted by in vitro and in vivo 
methods, physical properties (e.g. mass weight and molecular weight) and mechanical properties 
(e.g., tensile strength and elastic modulus) showed a difference during scaffold degradation. A 
large number of clinical trials in human indicated the safety and efficacy of polymeric scaffolds in 
treatment of coronary artery disease, and a series of in vivo studies in animals also showed that 
the polymeric scaffolds offered the benefits for the treatment of biliary disease. However, 
experimental studies are still limited due to the microscale geometry of scaffold and complex 
environment of human artery, and systematic efforts are urgently required in order to provide an 
improved understanding of this both clinically and scientifically important phenomenon. 
 
8. Conclusions 
Scaffold-artery interaction was simulated by incorporating changes in scaffold material behaviour 
over time while simultaneously including vessel remodelling changes (such as lumen gain and 
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plaque/artery thickening) that occur during the timeframe of scaffold degradation. The von 
Mises stress variation on the scaffold was consistent with the change of yield stress for scaffold 
material, whereas the stresses in the plaque-artery system generally reduced over time but varied 
by tissue layer. Overall, the results generated support that the interaction of the Absorb scaffold 
with the artery wall is stable throughout the first year after deployment, and is thereafter 
associated with gradually reducing stresses in the plaque-artery system as the vessel remodels. It 
seems that property degradation is mainly responsible for stress drop in the system, with 
additional contributions from vessel remodelling. Also, this work represents a first attempt at 
studying scaffold-vessel interaction by combining material property degradation behaviour with 
anticipated vessel wall changes after deployment of a bioresorbable scaffold. As such, modelling 
limitations are present but can be overcome in future work. 
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